Nicola Rohrseitz — investor profile photo

Nicola Rohrseitz

Executive Director at Defitech Foundation | Leading Brain-Computer Interfaces at GESDA | EPFL MSc, ETH PhD

📍 Geneva, Geneva, Switzerland🔄 Updated November 2026💼 3 investments📅 13 years investing🗓 Last invested Sep 2019𝕏 @upgrade_to_unlock
VC🌍 Switzerland
3
Total investments
0
Early stage
2
Mid stage
0
Late stage
13y
Years active

Portfolio

2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Aug 2015
Gondola Medical Technologies SA is a Swiss Company specializing in rehabilitation therapies for patients with neurological conditions. It has developed and patented the GONDOLA® medical device to deliver the AMPS treatment (Automated Mechanical Peripheral Stimulation) for the walking and balance rehabilitation of people living with Parkinson’s disease and stroke. The GONDOLA® device has been developed in two versions: - one to be used at home, no need of caregiver or specialized support during use. Its use requires few minutes, benefits remain for a period ranging from 2 to 4 days. Regular use of the device twice a week allows to maintain benefits overtime. - one to be used in medical settings like hospitals, rehab and phisiotherapy centers, nursing homes. email us for to get more information: info@gondola.org
Board Member
Sep 2013
3D Scene Understanding by applying AI, Robotics, Machine Learning, and Neuroscience to Computer Vision
Experience · 8 entries
All (8)
Investments (3)
Founder (3)
Board (3)
2025
Co-founder, Brain-Computer Interfaces Initiative
Oct 2025
GESDA focusses on science and diplomacy anticipation. The goal of the Foundation is to explore how advances in science and technology can most efficiently be translated into and used as tools for the benefit of humanity as a whole. It wants to interlink the digital revolution with other disruptive fields of science and with the diplomacy world.
late stageThink Tanks
2019
Board Member
Sep 2019
Ex Machina is a competence center for open source technologies and a provider of high-quality IT professional services. We have teamed up some of the best professionals in open source technologies to ensure "Made in Switzerland"​ development standards. Our software development and test process is based on best-of-breed agile methodologies where the Client is always in control of the project. We offer cloud computing hosting and support for our business solutions through SLA-based contracts. Ex Machina consulting services also include support to build IT strategies and innovative business solutions while ensuring governance of new risks as well as to remain in compliance of open source licence obligations.
2015
Board Member
Aug 2015
Gondola Medical Technologies SA is a Swiss Company specializing in rehabilitation therapies for patients with neurological conditions. It has developed and patented the GONDOLA® medical device to deliver the AMPS treatment (Automated Mechanical Peripheral Stimulation) for the walking and balance rehabilitation of people living with Parkinson’s disease and stroke. The GONDOLA® device has been developed in two versions: - one to be used at home, no need of caregiver or specialized support during use. Its use requires few minutes, benefits remain for a period ranging from 2 to 4 days. Regular use of the device twice a week allows to maintain benefits overtime. - one to be used in medical settings like hospitals, rehab and phisiotherapy centers, nursing homes. email us for to get more information: info@gondola.org
2013
Board Member
Sep 2013
3D Scene Understanding by applying AI, Robotics, Machine Learning, and Neuroscience to Computer Vision
Associate participant
Apr 2013
Techstars helps founders scale their startups into world-changing businesses. Founded in 2006, Techstars is on a mission to invest in startups to enable more capital to flow to more entrepreneurs around the world in order to deliver exceptional returns to our investors. We do this by operating accelerator programs and venture capital funds, as well as by connecting startups, investors, corporations, and cities to help build thriving startup communities. Our results show why Techstars is Better for Founders than any other global accelerator: On average, 74.5% of Techstars companies will raise money within 3 years of their program; 18.5% of Techstars portfolio companies have exited 5 years after their program and 31.1% after eight years. (PitchBook June 2023)
Show all 8 entries ↓
Investment activity
2013–2019 · 3 investments
201312015120191
Recent (last 2 years)Earlier
Investor lists
Lists that match Nicola's portfolio